Photon-Counting Computed Tomography (PCCT) has emerged as one of the most significant innovations in diagnostic imaging by introducing photon-counting detector technology capable of overcoming several intrinsic limitations of conventional energy-integrating detector computed tomography. This review analyzes the technological principles underlying PCCT, its integration with artificial intelligence, current clinical applications, implementation challenges, and future perspectives in precision medicine. A structured review of the contemporary scientific literature was conducted using internationally recognized biomedical databases and peer-reviewed publications focusing on detector technology, spectral imaging, quantitative imaging biomarkers, radiation dose optimization, and multidisciplinary clinical applications. The reviewed evidence consistently demonstrated that PCCT provides superior spatial resolution, improved contrast-to-noise ratio, enhanced spectral imaging, quantitative tissue characterization, and substantial reduction of electronic noise and beam-hardening artifacts while maintaining lower radiation exposure than conventional CT systems. The greatest clinical benefits were observed in cardiovascular imaging, oncology, neurology, pediatric radiology, pulmonary imaging, abdominal imaging, and musculoskeletal applications. The integration of artificial intelligence further enhances image reconstruction, automated segmentation, lesion detection, radiomics, workflow optimization, and quantitative image analysis, facilitating increasingly individualized diagnostic assessment. Despite important challenges related to acquisition costs, infrastructure requirements, protocol standardization, and broader clinical implementation, the available evidence supports Photon-Counting Computed Tomography as a transformative technology with the potential to redefine diagnostic imaging and strengthen the development of precision medicine across diverse healthcare systems.
A. F. Ortega, Eileen Julliette Orantes Zacaríaz, M. B. Apráez et al.· International science journa...· 0 citations
Overall, liquid biopsy represents a transformative strategy that complements conventional tissue biopsy and supports more personalized, dynamic, and evidence-based management of solid tumors.
Ricardo Fernando Rincón Veloz, Ana Milena Murgas Acevedo, Gerardo Amaya Villagran et al.· International science journa...· 0 citations
The available evidence suggests that continued multidisciplinary collaboration and technological innovation will facilitate the progressive integration of BCIs into routine neurosurgical care, supporting personalized therapeutic strategies aimed at improving functional recovery, communication, and quality of life in patients with complex neurological disorders.
Alejandra Mendoza Ortiz, Marco Antonio Ortiz Ayala, Robinson Alexander Morey Contreras et al.· International science journa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.